Marianna Foldvari

Professor, School of Pharmacy

Research interests: bio-nanotechnology - novel strategies for improved transdermal delivery systems


Biography

Marianna Foldvari is a Professor and served as the Associate Director for research and graduate studies in the past 4 years at the University of Waterloo’s School of Pharmacy. Foldvari’s expertise is in pharmaceutics, dosage form and drug delivery system design and pharmaceutical nanotechnology. She has over 20 years of experience as an academic researcher and in research and development in the pharmaceutical industry through technology transfer activities.

Foldvari is an internationally recognized expert in nanomedicine. Her research program focuses on the development of intelligent and non-invasive drug delivery systems design for protein drugs, gene therapy and pharmaceutical development of nano-enabled products.

Foldvari developed Biphasix™, a needle-free drug delivery system for dermal delivery of drugs. Important characteristics of the delivery systems are improved drug encapsulation and drug permeation through the skin.

She is Associate Editor of Nanomedicine: Nanotechnology, Biology and Medicine, Editorial Board Member and Hot Topic Editor for Current Drug Delivery, the Journal of Nanomedicine and Biotherapeutic Discovery, the Journal of Bionanoscience and the International Journal of Pharmaceutical Compounding.

She is the founding Director of the American Society for Nanomedicine (ASNM) and the International Society of Nanomedicine (ISNM). She served as board member for Genome Prairie and was a member of the advisory committee to the Prime Minister on Science and Technology and was a Founder of the Canadian Society of Pharmaceutical Sciences (CSPS). She has received the Young Women's Christian Association (YWCA) Women of Distinction Award and the Sabex Award of Innovation.

Foldvari has authored more than 100 papers and 70 conference presentations and is the inventor on 15 patents. She is a frequently invited speaker at national and international conferences on gene and protein delivery systems and nanomedicine development and applications. She founded two spin-off companies that focus on nanomedicine product development to commercialize technologies that she and her research team have developed.

Education

  • PhD, Pharmaceutical Sciences, Dalhousie University
  • Doctor of Pharmaceutical Sciences, Semmelweis Medical University, Budapest, Hungary
  • BSc, Pharmacy, Semmelweis Medical University, Budapest, Hungary

Marianna Foldvari

 
    Affiliation: 
    University of Waterloo